Physician profile
John R Hratko
NPI 1659369841
$1,115.22
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $12.37 · 2021: $143 · 2022: $288 · 2023: $400 · 2024: $45.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.44 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $227.31 | 2022-2023 | |
| Myovant Sciences INC. | $189.14 | 2021-2022 | |
| Avion Pharmaceuticals | $110.93 | 2019 | |
| Pfizer INC. | $76.86 | 2022-2023 | |
| Astellas Pharma US INC | $45.12 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $34.29 | 2019-2021 | |
| Evofem Biosciences, INC. | $21.78 | 2021 | |
| Exeltis, USA INC. | $19.52 | 2023 | Slynd |
| Exact Sciences Corporation | $19.18 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $13.65 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hratko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.